The ITGA3 gene helps cells stick to the thin support layer that holds tissues together, especially in the skin, lungs, and kidneys. In medicine, this gene is important because it supports the attachment and repair of these tissues. If the gene does not work properly, some people can have fragile skin with blistering, breathing problems from lung disease, and kidney problems that may appear early in life. These effects are linked to inherited variants that reduce how well cells stay anchored in place.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to make proteins, the parts of cells that do the work. Others mainly help control when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, and medications. To explore this topic further, you can find more in the LearnHub.
Overview
ITGA3Gene function
What if the gene works
The ITGA3 gene helps make part of a protein on the cell surface that lets cells attach to nearby support tissue. This supports stable skin, kidney filters, and lung air sacs.
Risk
What if the gene does not work
More disruptive variants in the ITGA3 gene can affect the lungs, kidneys, and skin, often causing breathing problems, protein in urine, and fragile skin. Milder or more severe variants can change when symptoms appear and how strong they are.
Treatment
What does that mean for your treatment
No treatment or drug selection approach specific to the ITGA3 gene is currently established. The ITGA3 gene is being studied as a biomarker and possible drug target in some cancers, but this does not yet guide treatment for inherited conditions linked to this gene.
Conditions associated with ITGA3
Gene function
What if the gene works
The ITGA3 gene helps cells hold on to the thin support layer around them and respond to cues from their surroundings. This is especially important in tissues that need strong, orderly cell layers. When this gene is working as expected, cells can stay anchored, communicate with nearby structures, and help maintain normal tissue architecture.
The ITGA3 gene helps form a cell surface receptor that lets cells attach to laminin, a support protein in the basement membrane. This steady grip helps cells stay in the right place.
After a cell attaches, this receptor passes signals between the outside and inside of the cell. These signals help guide cell shape, movement, and routine cell survival.
By supporting how cells attach to the basement membrane, the ITGA3 gene helps keep cell layers orderly in tissues such as the skin, lungs, and kidneys. This supports normal structure and day to day function.
What is a variant?
Genetic variants are small changes in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ITGA3 gene can make the alpha3 integrin protein shortened, unstable, or unable to join its partner and reach the cell surface. This is how variants in the ITGA3 gene affect protein function: cells lose some attachment and signaling. Milder missense variants may leave residual activity, while more severe loss of function variants can nearly abolish it. Greater loss often links to earlier, broader lung, kidney, and skin involvement.
How variants are linked to conditions
Pathogenic variants in the ITGA3 gene can cause a rare inherited condition marked by kidney disease, lung disease, and fragile skin, often described as interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa (ILNEB). In practice, the main health conditions linked to ITGA3 gene variants involve breathing problems, protein loss from the kidneys, and skin blistering that may begin early in life. A pathogenic variant in the ITGA3 gene can confirm this diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely found in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a firm diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ITGA3, risk is mainly shaped by inheritance: the chance is higher when both parents carry a harmful ITGA3 change, and family history can matter. Beyond that, there is not yet broadly confirmed evidence that lifestyle or other outside factors meaningfully increase or lower the chance of developing an ITGA3-related condition.
Inheritance of ITGA3 variants
ITGA3-related conditions are inherited in an autosomal recessive pattern. In practical terms, how ITGA3 gene variants are inherited usually means a child needs to receive one altered copy of the ITGA3 gene from each parent to be affected. Parents who each carry one variant are often unaffected themselves, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. This pattern applies to the well-established condition linked to the ITGA3 gene.
What does my ITGA3 result mean for my family?
Changes in the ITGA3 gene linked to disease are usually passed down in a recessive pattern, which means parents are often healthy carriers. For family members, this can mean brothers and sisters may also be affected or may be carriers, and other relatives may carry the same gene change without knowing it. This is most relevant when a known ITGA3-related condition has been confirmed in the family.
Genetic information
Genetic testing
How you find out about variants
To find out about variants, ITGA3 genetic testing reads the ITGA3 gene from a blood, saliva, or cheek swab sample and looks for changes in its DNA code. Results may identify a pathogenic variant, a benign variant, or a variant of uncertain significance, which means the health effect is not yet clear.
When should I consider getting a genetic test?
ITGA3 testing may be considered when a baby or child has a rare combination of serious breathing problems, kidney disease, and fragile or blistering skin, or when this pattern runs in the family. It can also help clarify whether parents are carriers after an affected child is diagnosed.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the specific type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly, while another may process it faster or be more sensitive to its effects. This is a common reason the same treatment can work well for some people, work less well for others, or cause more side effects in certain individuals.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect either how strongly a drug works or how the body handles it. This information can support more informed, more individualized treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the ITGA3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for changes in this gene in guiding how medicines are chosen or used. Questions about symptoms, treatment choices, or side effects are best discussed with your doctor or pharmacist.
History
Researchers identified the ITGA3 gene during the broader wave of integrin research in the late 1980s and early 1990s, when scientists were mapping the proteins that help cells attach to their surroundings. Early studies described the alpha 3 part of this cell-surface receptor before the gene itself was fully characterized. From these first observations, research expanded steadily. Later work connected rare, inherited ITGA3 variants with a condition affecting the lungs, kidneys, and skin, which gave the gene clearer clinical importance. That link helped move ITGA3 from basic laboratory research into medical genetics. Over time, descriptions became more precise as genetic testing made it easier to confirm the diagnosis in affected families.